Possible Recognition of Atherosclerosis Regression in Humans

  • K. W. Walton


Evidence is accumulating from countries throughout the developed areas of the world that both coronary heart disease and strokes are declining in incidence.1,2 An interesting exception is Sweden, where recent reports suggest a continuing increase in incidence of these forms of cardiovascular disease.3,4 Where the incidence of diseases associated with atherosclerosis is decreasing, it is not clear whether the phenomenon is due to prevention of the occurrence of arterial disease, to slowing of its rate of progress, to an actual regression of established disease, or even to all three of these events.


Veteran Administration Fatty Streak Portacaval Shunt Aortic Lesion Uveal Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Editorial, Why the American decline in coronary heart disease? Lancet 1: 183 (1980).Google Scholar
  2. 2.
    Editorial, Why has stroke mortality declined? Lancet 1: 1195 (1983).Google Scholar
  3. 3.
    L. Welin, B. Larsson, K. Svardsudd, L. Wilhelmsen and G. Tibblin, Why is the incidence of ischaemic heart disease in Sweden increasing? Study of men born in 1913 and 1923, Lancet 1: 1087 (1983).CrossRefGoogle Scholar
  4. 4.
    L. Alfredsson, Ahlbom, Increasing incidence and mortality from myocardial infarction in Stockholm count, Br. Med. J. 286: 1931 (1983).CrossRefGoogle Scholar
  5. 5.
    Report from the Committee of Principal Investigators. A co-operative trial in the primary prevention of ischaemic heart disease using Clofibrate, Br. Heart J. 40: 1069 (1978).CrossRefGoogle Scholar
  6. 6.
    W. D. Zinserling, Untersuchungen über Atherosklerose. I. Über die aortaverfettung bei kindern, Virchows Arch. Pathol. Anat. Physiol. 255: 677 (1925).CrossRefGoogle Scholar
  7. 7.
    L. Aschoff, Die Arteriosklerose (Arteriopathia deformans). Ein Ernährungs—und Abmitzungproblem, Beih. Med. Klin. 26: 1 (1930).Google Scholar
  8. 8.
    H. Malmros, The relation of nutrition to health: A statistical study of the effects of the war-time on arteriosclerosis, tuberculosis and diabetes, Acta Med. Scand. Suppl. 246: 137 (1950).Google Scholar
  9. 9.
    A Strøm and R. A. Jensen, Mortality from circulatory diseases in Norway, 1940–1945, Lancet 1: 126 (1951).CrossRefGoogle Scholar
  10. 10.
    P. O. Yates, A change in the pattern of cerebrovascular disease, Lancet 1: 65 (1964).CrossRefGoogle Scholar
  11. 11.
    P. Helweg-Larsen, H. Hoffmeyer, J. Kieler, J. H. Thaysen, P. Thygesen and M. H. Wulff, Famine disease in German concentration camps—complications and sequels, Acta Med. Scand. 144(Suppl. 274): 284 (1952).Google Scholar
  12. 12.
    S. Dayton, M. L. Pearce, S. Hashimoto, W. J. Dixon and U. Tomiyasu, A controlled trial of a diet high in unsaturated fat in preventing complications of atherosclerosis, Circulation 40(Suppl. 2): 1 (1969).CrossRefGoogle Scholar
  13. 13.
    M. Miettinen, O. Turpeinen, M. J. Karvonen, R. Eluoso and E. Paavilainen, Effect of cholesterol lowering diet on mortality from coronary heart disease and other causes, Lancet 2: 835 (1972).CrossRefGoogle Scholar
  14. 14.
    M. F. Oliver, Diet and coronary heart disease, Br. Med. Bull. 37: 49 (1981).Google Scholar
  15. 15.
    K. W. Walton, Atherosclerosis, in “Textbook of Geriatric Medicine and Gerontology,” J. C. Brockelhurst, ed., 2nd ed. Churchill Livingstone, Edinburgh (1978).Google Scholar
  16. 16.
    E. P. McCullagh and L. A. Lewis, A study of diet, blood lipids and vascular disease in Trappist monks, N. Engl. J. Med. 263: 569 (1960).CrossRefGoogle Scholar
  17. 17.
    J. J. Groen, K. B. Tijong, A. Koster, A. F. Willebrands, G. Verdonck and M. Pierloot, The influence of nutrition and ways of life on blood cholesterol and the prevalence of hypertension and coronary artery disease among Trappist and Benedictine monks, Am. J. Clin. Nutr. 10: 456 (1962).Google Scholar
  18. 18.
    K. Kirkeby, Blood lipids, lipoproteins and proteins in vegetarians, Acta Med. Scand. 179: 443 (1966).Google Scholar
  19. 19.
    H. Buchwald and R. L. Varco, Partial ileal bypass for hyper-cholesterolaemia and atherosclerosis, Surg. Gynecol. Obstet. 124: 1231 (1967).Google Scholar
  20. 20.
    T. E. Starzl, H. P. Chase, C. W. Putnam and K. A. Porter, Portacaval shunt in hyperlipoproteinaemia, Lancet 2: 940 (1973).CrossRefGoogle Scholar
  21. 21.
    T. E. Starzl, H. P. Chase, C. W. Putnam and J. J. Nota, Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia, Lancet 2: 714 (1974).CrossRefGoogle Scholar
  22. 22.
    G. R. Thompson, R. Lowenthal and N. B. Myant, Plasma exchange in the management of homozygous familial hypercholesterolemia, Lancet 1: 1208 (1975).CrossRefGoogle Scholar
  23. 23.
    T. E. Starzl, L. Kolp and R. Weil, Portacaval shunt for Type II hyperlipidaemia, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  24. 24.
    H. Buchwald, R. B. Moore and R. L. Varco, Partial ileal by-pass: A test of the lipid-atherosclerosis hypothesis, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  25. 25.
    E. A. Stein and C. J. Glueck, Homozygous hypercholesterolaemia: Treatment by portacaval shunt, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  26. 26.
    G. R. Thompson, N. Myant, C. Oakley, R. Steiner and R. Sapsford, Combined medico-surgical strategy for severe familial hypercholesterolaemia, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  27. 27.
    K. W. Walton, The metabolism of low-density lipoproteins in health and disease, in “Physiology and Pathophysiology of Protein Metabolism,” G. Birke, R. Norburg and L. Plantin, eds., Pergamon Press, Oxford (1969).Google Scholar
  28. 28.
    P. J. Hurley and P. J. Scott, Plasma turnover of S 0–9 low-density lipoprotein in normal men and women, Atherosclerosis 11: 51 (1979).CrossRefGoogle Scholar
  29. 29.
    K. W. Walton, P. J. Scott, J. Verrier Jones, R. F. Fletcher and T. P. Whitehead, Studies on low-density lipoprotein turnover in relation to atromid therapy, J. Atheroscler. Res. 3: 396 (1963).CrossRefGoogle Scholar
  30. 30.
    P. J. Scott and P. J. Hurley, Low-density lipoprotein accumulation in aortic and coronary artery walls, Israel J. Med. Sci. 5: 631 (1969).Google Scholar
  31. 31.
    P. J. Scott and P. J. Hurley, The distribution of radioiodinated serum albumin and low-density lipoprotein in tissues and the arterial wall, Atherosclerosis 11: 77 (1970).CrossRefGoogle Scholar
  32. 32.
    D. Steinberg, R. C. Pittman, A. D. Attie, T. E. Carew, S. Pangburn and D. Weinstein, The role of the liver in LDL catabolism, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  33. 33.
    K. W. Walton, P. J. Scott, P. W. Dykes and J. W. L. Davies, The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131I-low density lipoproteins in hyperthyroidism and thyrotoxicosis, Clin. Sci. 29: 217 (1965).Google Scholar
  34. 34.
    J. E. French, Endothelial structure and function, in “Evolution of the Atherosclerotic Plaque,” R. J. Jones, eds., Chicago University Press, Chicago (1963).Google Scholar
  35. 35.
    J. C. F. Poole and H. W. Florey, Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits, J. Pathol. Bacteriol. 75: 245 (1958).CrossRefGoogle Scholar
  36. 36.
    J. L. Goldstein and M. S. Brown, Binding and degradation of low-density lipoproteins by cultured human fibroblasts: comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolaemia, J. Br. Chem. 249: 5153 (1974).Google Scholar
  37. 37.
    J. L. Goldstein and M. S. Brown, The low-density lipoprotein pathway and its relation to atherosclerosis, Annu. Rev. Biochem. 46: 897 (1977).CrossRefGoogle Scholar
  38. 38.
    R. W. Mahley, T. L. Innerarity, K. H. Weisgraber and S. Y. Oh, Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modifications of lysine residues of the apoproteins, J. Clin. Invest. 64: 743 (1976).CrossRefGoogle Scholar
  39. 39.
    M. S. Brown, S. K. Basu, J. R. Falek and J. L. Goldstein, The scavenger cell pathway for lipoprotein degradation: Specifity of the binding site that mediates the uptake of negatively-charged LDL by macrophages, J. Supramol. Struct. 13: 67 (1980).CrossRefGoogle Scholar
  40. 40.
    J. C. Geer and M. D. Haust, “Smooth Muscle Cells in Atherosclerosis,” Karger, Basel (1972).Google Scholar
  41. 41.
    J. L. Titus and D. G. Weilbaecher, Smooth muscle cells in atherosclerosis, in “Atherosclerosis V,” A. M. Gotto, L. C. Smith and B. Allen, eds., Springer-Verlag, New York (1980).Google Scholar
  42. 42.
    T. Schaffner, K. Taylor, E. J. Bartucci, K. Fischer-Dzoga, J. H. Beeson, S. Glagov and R. W. Wissler, Arterial foam-cells with distinctive immunomorphologic and histochemical features of macrophages, Am. J. Pathol. 100: 57 (1980).Google Scholar
  43. 43.
    K. W. Walton and N. Williamson, Histological and immuno-fluorescent studies on the evolution of the human atheromatous plaque, J. Atheroscler. Res. 8: 599 (1968).CrossRefGoogle Scholar
  44. 44.
    K. W. Walton, D. J. Dunkerley, A. G. Johnson, M. K. Khan, C. J. Morris and R. Watts, Investigation by immunofluorescence of arterial lesions in rabbits on two different lipid supplements and treated with pyridinol carbamate, Atherosclerosis 23: 117 (1976).CrossRefGoogle Scholar
  45. 45.
    K. W. Walton, C. Thomas and D. J. Dunkerley, The pathogenesis of cutaneous xanthomata, J. Pathol. 109: 271 (1972).CrossRefGoogle Scholar
  46. 46.
    K. W. Walton, The role of altered vascular permeability in the induction of experimental xanthomata, Nutr. Metab. 15: 59 (1973).CrossRefGoogle Scholar
  47. 47.
    K. W. Walton and D. J. Dunkerley, Studies on the pathogenesis of corneal arcus formation. II. Immunofluorescent studies on lipid deposition in the eye of the lipid-fed rabbit, J. Pathol. 114: 217 (1974).CrossRefGoogle Scholar
  48. 48.
    R. C. Curran and W. A. J. Crane, Muco-polysaccarides in the atheromatous aorta, J. Pathol. Bacteriol. 84: 405 (1962).CrossRefGoogle Scholar
  49. 49.
    C. W. M. Adams, O. B. Bayliss, M. Z. Ibrahim and M. W. Webster, Phospholipids in atherosclerosis: the modification of the cholesterol granuloma by phospholipid, J. Pathol. Bacteriol. 86: 431 (1963).CrossRefGoogle Scholar
  50. 50.
    G. J. Miller and N. E. Miller, Plasma high-density lipoprotein concentration and development of ischaemic heart disease, Lancet 1: 16 (1975).CrossRefGoogle Scholar
  51. 51.
    G. V. H. Bradby, A. J. Valente and K. W. Walton, Serum high-density lipoproteins in peripheral vascular disease, Lancet 2: 1271 (1978).CrossRefGoogle Scholar
  52. 52.
    J. A. Glomset, The plasma lecithin: cholesterol acyltransferase reaction, J. Lipid Res. 9: 155 (1968).Google Scholar
  53. 53.
    T. E. Carew, T. Koschinsky, S. B. Hayes and D. Steinberg, A mechanism by which high density lipoproteins may slow the atherogenic process, Lancet 1: 1315 (1976).CrossRefGoogle Scholar
  54. 54.
    R. J. Levy and B. M. Rifkind, The structure, function and metabolism of high-density lipoproteins: A status report, Circulation 62(Suppl. 4): 4 (1980).Google Scholar
  55. 55.
    K. W. Walton, Immunohistology of aortic fatty streaks in children and adults, in “Atherosclerosis VI,” F. G. Schettler, A. M. Gotto, G. Middlehoff, A. J. R. Habenicht and K. Jurutka, eds., Springer-Verlag, Berlin (1983).Google Scholar
  56. 56.
    J. R. A. Mitchell and C. J. Schwartz, “Arterial Disease,” Blackwell, Oxford (1965).Google Scholar
  57. 57.
    T. A. Pearson, J. M. Dillman, K. Solez and R. H. Heptinstall, Evidence for two populations of fatty streaks with different roles in the atherogenic process, Lancet 2: 496 (1980).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • K. W. Walton
    • 1
  1. 1.Department of Investigative PathologyThe University of BirminghamBirminghamEngland

Personalised recommendations